Co-design and ethical artificial intelligence for health: An agenda for critical research and practice

Applications of artificial intelligence/machine learning (AI/ML) in health care are dynamic and rapidly growing. One strategy for anticipating and addressing ethical challenges related to AI/ML for health care is patient and public involvement in the design of those technologies - often referred to as 'co-design'. Co-design has a diverse intellectual and practical history, however, and has been conceptualized in many different ways. Moreover, AI/ML introduces challenges to co-design that are often underappreciated. Informed by perspectives from critical data studies and critical digital health studies, we review the research literature on involvement in health care, and involvement in design, and examine the extent to which co-design as commonly conceptualized is capable of addressing the range of normative issues raised by AI/ML for health care. We suggest that AI/ML technologies have amplified and modified existing challenges related to patient and public involvement, and created entirely new challenges. We outline three pitfalls associated with co-design for ethical AI/ML for health care and conclude with suggestions for addressing these practical and conceptual challenges.

Automated summary

The use of AI/ML in healthcare is growing rapidly, making patient and public involvement in the design of these technologies more crucial. However, there are challenges and limitations to co-design as a strategy due to the introduction of new technologies like AI/ML. These new technologies have amplified and modified existing challenges related to patient and public involvement, creating the need to address both old and new issues.